Meet Rob Etherington, President & CEO of Clene, with nearly 30 years in pharmaceuticals. He's led at Actelion Pharmaceuticals and Pfizer's Parke-Davis, overseeing major drug launches. At Clene, he's raised over $150M and drives focus on neurodegenerative diseases. Join us to learn from his leadership journey!
